Journal of Endocrinological Investigation

, Volume 31, Issue 9, pp 773–778 | Cite as

Hypothyroidism is associated with increased myostatin expression in rats

  • I. Carneiro
  • I. Castro-Piedras
  • A. Muñoz
  • J. L. Labandeira-García
  • J. Devesa
  • V. M. Arce
Original Articles

Abstract

Besides its key role in the regulation of muscle growth during development, myostatin also appears to be involved in muscle homeostasis in adults, and its expression is upregulated during muscle atrophy. Since muscle physiology is greatly influenced by thyroid status, and the myostatin promoter region contains several putative thyroid hormone response elements, in the present study we examined the possible role of thyroid hormones in the regulation of myostatin gene expression. Adult male rats were made either hypothyroid or hyperthyroid by means of administration of 0.1% amino-triazole (AMT) in drinking water for 4 weeks, or daily injections of Levo-T4 (L-T4) (100 μg/rat) for 3 weeks, respectively. At the end of the treatment period, both myostatin mRNA and protein content were increased in AMT-treated rats in relation to control rats. In contrast, no changes in myostatin mRNA levels were detected in L-T4-treated rats. The role of thyroid hormones in the regulation of myostatin expression was also investigated in C2C12 cells in vitro. Treatment of C2C12 cells with thyroid hormones stimulated their differentiation into multinucleated myotubes, but did not induce any change in myostatin mRNA abundance. In all, our findings demonstrate that myostatin expression is increased in hypothyroid rats, thus supporting a possible role for this factor in the pathogenesis of the muscle loss that may occur in hypothyroidism.

Key-words

Hyperthyroidism hypothyroidism myostatin thyroid hormones 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387: 83–90.PubMedCrossRefGoogle Scholar
  2. 2.
    Grobet L, Martin LJ, Poncelet D, et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 1997, 17: 71–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Kambadur R, Sharma M, Smith TP, Bass JJ. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res 1997, 7: 910–6.PubMedGoogle Scholar
  4. 4.
    McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A 1997, 94: 12457–61.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Szabó G, Dallman G, Müller G, Patthy L, Soller M, Varga L. A deletion in the myostatin gene causes the compact (Cmpt) hypermuscular mutation in mice. Mamm Genome 1998, 9: 671–2.PubMedCrossRefGoogle Scholar
  6. 6.
    Schuelke M, Wagner KR, Stolz LE, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004, 350: 2682–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Reisz-Porszasz S, Bhasin S, Artaza JN, et al. Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab 2003, 285: E876–88.PubMedGoogle Scholar
  8. 8.
    Whittemore LA, Song K, Li X, et al. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 2003, 300: 965–71.PubMedCrossRefGoogle Scholar
  9. 9.
    Grobet L, Pirottin D, Farnir F, et al. Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene. Genesis 2003, 35: 227–38.PubMedCrossRefGoogle Scholar
  10. 10.
    Welle S, Bhatt K, Pinkert CA, Tawil R, Thornton CA. Muscle growth after post-developmental myostatin gene knockout. Am J Physiol Endocrinol Metab 2007, 292: E985–91.PubMedCrossRefGoogle Scholar
  11. 11.
    Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A 1998, 95: 14938–43.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Schulte JN, Yarasheski KE. Effects of resistance training on the rate of muscle protein synthesis in frail elderly people. Int J Sport Nutr Exerc Metab 2001, 11: S111–8.PubMedGoogle Scholar
  13. 13.
    Yarasheski KE, Bhasin S, Sinha-Hikim I, Pak-Loduca J, Gonzalez-Cadavid NF. Serum myostatin-immunoreactive protein is increased in 60–92 year old women and men with muscle wasting. J Nutr Health Aging 2002, 6: 343–8.PubMedGoogle Scholar
  14. 14.
    Zachwieja JJ, Smith SR, Sinha-Hikim I, Gonzalez-Cadavid N, Bhasin S. Plasma myostatin-immunoreactive protein is increased after prolonged bed rest with low-dose T3 administration. J Gravit Physiol 1999, 6: 11–5.PubMedGoogle Scholar
  15. 15.
    Reardon KA, Davis J, Kapsa RM, Choong P, Byrne E. Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve 2001, 7: 893–9.CrossRefGoogle Scholar
  16. 16.
    Carlson CJ, Booth FW, Gordon SE. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol 1999, 222: R601–6.Google Scholar
  17. 17.
    Wehling M, Cai B, Tidball JG. Modulation of myostatin expression during modified muscle use. FASEB J 2000, 14: 103–10.PubMedGoogle Scholar
  18. 18.
    Lalani R, Bhasin S, Byhower F, et al. Myostatin and insulin-like growth factor-I and II expresion in the muscle of rats exposed to the microgravity envoironment of the NeuroLab space shuttle fligh. J Endocrinol 2000, 167: 417–28.PubMedCrossRefGoogle Scholar
  19. 19.
    Ma K, Mallidis C, Artaza J, Taylor W, Gonzalez-Cadavid N, Bhasin S. Characterization of 5’-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Phsyiol Endocrinol Metab 2001, 281: E1128–36.Google Scholar
  20. 20.
    Rooyackers OE, Nair KS. Hormonal regulation of human muscle protein metabolism. Annu Rev Nutr 1997, 17: 457–85.PubMedCrossRefGoogle Scholar
  21. 21.
    Ma K, Mallidis C, Bhasin S, et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 2003, 285: E363–71.PubMedGoogle Scholar
  22. 22.
    López M, Seoane L, Señ arís RM, Diéguez C. Prepro-orexin mRNA levels in the rat hypothalamus, and orexin receptors mRNA levels in the rat hypothalamus and adrenal gland are not influenced by the thyroid status. Neurosci Lett 2001, 300: 171–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Ríos R, Carneiro I, Arce VM, Devesa J. Myostatin regulates cell survival during C2C12 myogenesis. Biochem Biophys Res Commun 2001, 280: 561–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Ríos R, Carneiro I, Arce VM, Devesa J. Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 2002, 282: C993–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Muscat GE, Mynett-Johnson L, Dowhan D, Downes M, Griggs R. Activation of myoD gene transcription by 3,5,3’-triiodo-L-thyronine: a direct role for the thyroid hormone and retinoid X receptors. Nucleic Acids Res 1994, 22: 583–91.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Zimmers TA, Davies MV, Koniaris LG, et al. Induction of cachexia in mice by systemically administered myostatin. Science 2002, 296: 1486–8.PubMedCrossRefGoogle Scholar
  27. 27.
    McFarlane C, Plummer E, Thomas M, et al. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J Cell Physiol 2006, 209: 501–14.PubMedCrossRefGoogle Scholar
  28. 28.
    Taylor WE, Bhasin S, Artaza J, et al. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab 2001, 280: E221–8.PubMedGoogle Scholar
  29. 29.
    Wu Y, Koenig RJ. Gene regulation by thyroid hormone. Trends Endocrinol Metab 2000, 11: 207–11.PubMedCrossRefGoogle Scholar
  30. 30.
    Zhang J, Lazar MA. The mechanism of action of thyroid hormones. Annu Rev Physiol 2000, 62: 439–66.PubMedCrossRefGoogle Scholar
  31. 31.
    Clément K, Viguerie N, Diehn M, et al. In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Res 2002, 12: 281–91.PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004, 287: C834–43.PubMedCrossRefGoogle Scholar
  33. 33.
    Lovejoy JC, Smith SR, Zachwieja JJ, et al. Low-dose T(3) improves the bed rest model of simulated weightlessness in men and women. Am J Physiol 1999, 277: E370–9.PubMedGoogle Scholar
  34. 34.
    McMahon CD, Popovic L, Oldham JM, et al. Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension. Am J Physiol Endocrinol Metab 2003, 285: E82–7.PubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2008

Authors and Affiliations

  • I. Carneiro
    • 1
  • I. Castro-Piedras
    • 1
  • A. Muñoz
    • 2
  • J. L. Labandeira-García
    • 2
  • J. Devesa
    • 1
  • V. M. Arce
    • 1
  1. 1.Department of PhysiologyUniversity of Santiago de CompostelaSantiago de Compostela, and CIBERNEDSpain
  2. 2.Department of Morphological SciencesUniversity of Santiago de CompostelaSantiago de Compostela, and CIBERNEDSpain

Personalised recommendations